Literature DB >> 1030820

Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.

J D Baggot, D A Gingerich.   

Abstract

The distribution and elimination kinetics of erythromycin and tylosin, which are macrolide antibiotics, were studied in healthy cows. A single dose (12-5 mg/kg) of drug was administered as an intravenous bolus, and blood samples were collected at precisely timed intervals. The standard cylinder plate bioassay method using Sarcina lutea as test organism was employed to determine antibiotic activity in the serum. The results suggested that these drugs are distributed in at least two kinetically distinct body compartments. By use of established mathematical techniques, values were assigned to the individual rate constants controlling distribution between the central and peripheral compartments and to the rate constant controlling overall elimination (beta) of each drug from the body. The calculated overall tissue to serum drug level ratios (k12/k21) after apparent distribution equilibrium was attained were 2-28 and 2-05 for erythromycin and tylosin, respectively. The half-life (mean+/-SD) of erythromycin was 3-16 h+/-0-44, while that of tylosin was 1-62 h+/-0-17. The total body clearance (ml/kg/min) values were 2-88+/-0-47 for erythromycin and 7-8+/-2-95 for tylosin. Analogue computer simulated curves of the antibiotic levels in the central and tissue compartments as wel as an elimination curve were generated. The tissue level of erythromycin reached a peak of 43 per cent of the dose at 67 min. At 6 h, the percentages of the dose of erythromycin in the central and tissue compartments and eliminated were 6, 19 and 75, respectively. The peak level of tylosin in the tissue compartment (26-5 per cent of the dose) was present at 30 min. At 4 h, 1 and 5 per cent of the dose were contained in the central and peripheral compartments, respectively, while 94 per cent had been eliminated. This single dose study provides information which is essential for the design of a satisfactory dosage regimen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1030820

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  A study of tilmicosin residues in milk following subcutaneous administration to lactating dairy cows.

Authors:  S L Helton-Groce; T D Thomson; R S Readnour
Journal:  Can Vet J       Date:  1993-10       Impact factor: 1.008

2.  Some comparative aspects of the pharmacokinetics of tylosin in buffaloes and cattle.

Authors:  A R Saurit; M Rubio; E Baroni; Andrés M San; S Sánchez; J C Boggio
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

3.  Pharmacokinetics of Tylvalosin in Broiler Turkeys (Meleagris Gallopavo) After Single Intravenous and Oral Administration.

Authors:  Mohamed Elbadawy; Mohamed Aboubakr; Amira Abugomaa
Journal:  Front Vet Sci       Date:  2019-10-17

4.  Distribution of Medically Relevant Antibiotic Resistance Genes and Mobile Genetic Elements in Soils of Temperate Forests and Grasslands Varying in Land Use.

Authors:  Inka M Willms; Jingyue Yuan; Caterina Penone; Kezia Goldmann; Juliane Vogt; Tesfaye Wubet; Ingo Schöning; Marion Schrumpf; François Buscot; Heiko Nacke
Journal:  Genes (Basel)       Date:  2020-01-30       Impact factor: 4.096

5.  Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.

Authors:  Tulay Avci; Muammer Elmas
Journal:  ScientificWorldJournal       Date:  2014-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.